Cite
HARVARD Citation
Simpson, E. et al. (2020). Efficacy and safety of abrocitinib in adults and adolescents with moderate-to-severe atopic dermatitis (JADE MONO-1): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial. Lancet. 396 (10246), pp. 255-266. [Online].